VPIM
Vanguard Personalized Indexing Management Portfolio holdings
AUM
$8.86B
This Quarter Return
+4.71%
1 Year Return
+26.43%
3 Year Return
+118.27%
5 Year Return
+211.61%
10 Year Return
–
AUM
$6.62B
AUM Growth
+$6.62B
(+6.6%)
Cap. Flow
+$353M
Cap. Flow
% of AUM
5.33%
Top 10 Holdings %
Top 10 Hldgs %
32.47%
Holding
1,907
New
132
Increased
1,128
Reduced
530
Closed
101
Top Buys
| 1 |
Apple
AAPL
|
$19.7M |
| 2 |
NVIDIA
NVDA
|
$19.7M |
| 3 |
Microsoft
MSFT
|
$17.9M |
| 4 |
Amazon
AMZN
|
$17.5M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$12.9M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$4.91M |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
$4.52M |
| 3 |
PepsiCo
PEP
|
$3.25M |
| 4 |
AGR
Avangrid, Inc.
AGR
|
$2.45M |
| 5 |
Adobe
ADBE
|
$2.31M |
Sector Composition
| 1 | Technology | 32.07% |
| 2 | Financials | 13.78% |
| 3 | Consumer Discretionary | 11.16% |
| 4 | Healthcare | 9.78% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Kopin
KOPN
$342M
| $17.3K | ﹤0.01% |
12,709
+2,160
| +20% | +$2.94K |
|
1777
Lexicon Pharmaceuticals
LXRX
$400M
| $17.2K | ﹤0.01% |
23,223
+3,301
| +17% | +$2.44K |
|
1778
Scilex Holding
SCLX
$124M
| $16.7K | ﹤0.01% |
39,172
+27,191
| +227% | +$11.6K |
|
1779
Assertio
ASRT
$80.4M
| $16.7K | ﹤0.01% |
19,170
+1,406
| +8% | +$1.23K |
|
1780
X4 Pharmaceuticals
XFOR
$84.2M
| $16.3K | ﹤0.01% |
+22,258
| New | +$16.3K |
|
|
QMMM
1781
QMMM Holdings Limited Class A Ordinary Shares
QMMM
$303M
| $16.2K | ﹤0.01% |
+12,654
| New | +$16.2K |
|
1782
Tenaya Therapeutics
TNYA
$184M
| $16.1K | ﹤0.01% |
+11,265
| New | +$16.1K |
|
1783
Nektar Therapeutics
NKTR
$568M
| $15.7K | ﹤0.01% |
16,847
+3,915
| +30% | +$3.64K |
|
1784
Prelude Therapeutics
PRLD
$68.5M
| $15.2K | ﹤0.01% |
+11,925
| New | +$15.2K |
|
1785
Tevogen Bio Holdings
TVGN
$179M
| $15.1K | ﹤0.01% |
+14,643
| New | +$15.1K |
|
|
JBDI
1786
JBDI Holdings Limited Ordinary Shares
JBDI
$20.2M
| $14.8K | ﹤0.01% |
+22,709
| New | +$14.8K |
|
1787
Lyell Immunopharma
LYEL
$213M
| $14.3K | ﹤0.01% |
+22,377
| New | +$14.3K |
|
1788
Ocugen
OCGN
$319M
| $14.1K | ﹤0.01% |
17,502
-1,248
| -7% | -$1.01K |
|
1789
CERo Therapeutics
CERO
$9.06M
| $14.1K | ﹤0.01% |
+234,657
| New | +$14.1K |
|
|
URG
1790
Ur-Energy
URG
$507M
| $13.9K | ﹤0.01% |
12,066
+546
| +5% | +$628 |
|
1791
Editas Medicine
EDIT
$231M
| $13.4K | ﹤0.01% |
10,569
-2,691
| -20% | -$3.42K |
|
1792
Gossamer Bio
GOSS
$562M
| $13.2K | ﹤0.01% |
14,564
+2,510
| +21% | +$2.27K |
|
1793
Odyssey Marine Exploration
OMEX
$88.6M
| $13K | ﹤0.01% |
+18,012
| New | +$13K |
|
1794
CarParts.com
PRTS
$45.3M
| $13K | ﹤0.01% |
12,003
+692
| +6% | +$747 |
|
1795
Femasys
FEMY
$11.6M
| $12.8K | ﹤0.01% |
11,618
| – | – |
|
1796
Verrica Pharmaceuticals
VRCA
$52.8M
| $12.6K | ﹤0.01% |
+18,069
| New | +$12.6K |
|
|
ELEV
1797
DELISTED
Elevation Oncology
ELEV
| $11.4K | ﹤0.01% |
+20,213
| New | +$11.4K |
|
|
BLMZ
1798
Harrison Global Holdings Inc. Ordinary Shares
BLMZ
$2.7M
| $11.3K | ﹤0.01% |
+19,730
| New | +$11.3K |
|
1799
La Rosa Holding
LRHC
$7.23M
| $10.6K | ﹤0.01% |
+12,502
| New | +$10.6K |
|
1800
Century Therapeutics
IPSC
$42.5M
| $10.3K | ﹤0.01% |
+10,214
| New | +$10.3K |
|